FDA organized a public hearing for a draft Chemical Act (2nd draft)

Food and Drug Administration (FDA), Ministry of Public Health, Thailand organized a public hearing for a draft Chemical Act (2^nd draft) on 21 October 2019. Approximately 100 participants audited a presentation given by FDA officer and joined a Q&A session.

The draft act is intended to replace existing framework of Hazardous Substance Act B.E. 2535 (1992), which is outdated after nearly 30 years of function. According to the article 36 of the draft Chemical Act (2^nd draft), manufacturer outside Thailand are required to appoint an authorized representative in Thailand for registration or application of risk assessment of chemicals.